GT
EXAS

Glenmede Trust’s Exact Sciences EXAS Stock Holding History

Glenmede Trust’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9
Closed – – 1552
2020
Q3 		$0 Hold
9
– – ﹤0.01% 2502
2020
Q2 		$0 Sell
9
-497
-98% -$39.7K ﹤0.01% 2494
2020
Q1 		$46K Hold
506
– – ﹤0.01% 1719
2019
Q4 		$46K Buy
506
+497
+5,522% +$43.7K ﹤0.01% 1719
2019
Q3 		$0 Sell
9
-188
-95% -$21.4K ﹤0.01% 3048
2019
Q2 		$23 Buy
197
+185
+1,542% +$18.6K ﹤0.01% 2009
2019
Q1 		$1 Sell
12
-41
-77% -$3.49K ﹤0.01% 2923
2018
Q4 		$3 Buy
+53
New +$3.64K ﹤0.01% 2666
2016
Q4 		– Sell
-45
Closed – – 2511
2016
Q3 		$0 Buy
+45
New +$793 ﹤0.01% 2607
2015
Q4 		– Sell
-56
Closed -$1K – 2683
2015
Q3 		$1K Hold
56
– – ﹤0.01% 2593
2015
Q2 		$1K Sell
56
-24,672
-100% -$620K ﹤0.01% 2533
2015
Q1 		$544K Hold
24,728
– – ﹤0.01% 925
2014
Q4 		$678K Hold
24,728
– – 0.01% 823
2014
Q3 		$479K Hold
24,728
– – ﹤0.01% 883
2014
Q2 		$421K Hold
24,728
– – ﹤0.01% 920
2014
Q1 		$350K Hold
24,728
– – ﹤0.01% 997
2013
Q4 		$290K Buy
+24,728
New +$284K ﹤0.01% 1033

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Glenmede Trust's EXAS Position: Q4 2020 in Review

Glenmede Trust sold out of Exact Sciences (EXAS) in Q4 2020, closing a stake of 9 shares.

Glenmede Trust first reported a position in EXAS in Q4 2013 and held it in 17 quarters. The position peaked at $678K in Q4 2014. 621 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

  • Glenmede Trust reported no remaining Exact Sciences position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 9 Exact Sciences shares in Q4 2020.
  • Glenmede Trust first reported a position in Exact Sciences in Q4 2013 and held it in 17 quarters.
  • Glenmede Trust's Exact Sciences position peaked at $678K in Q4 2014.
  • 621 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.